Mercer Global Advisors
COYA icon

Mercer Global Advisors’s Coya Therapeutics COYA Stock Holding History

Mercer Global Advisors’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.8K Buy
+7,320
New +$33.9K ﹤0.01% 4398

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mercer Global Advisors's COYA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Coya Therapeutics (COYA) in Q2 2026: 7,320 shares worth $42.8K. The stake represents ﹤0.01% of the portfolio and ranks #4398 among its holdings.

53 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Mercer Global Advisors held 7,320 shares of Coya Therapeutics worth $42.8K as of Q2 2026.
  • Coya Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Coya Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4398 holding.
  • 53 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.